Breaking Finance News

Vetr Inc. recorded Danaher Corporation (NYSE:DHR), raising its target price to $94.18 today

Danaher Corporation (NYSE:DHR) had its target price raised to $94.18 by Vetr Inc. in a report released 4/20/2017. The upped price target implies a potential upside of 0.14% from the company's previous stock price.

Previously on 4/4/2017, Zacks Investment Research released a statement about Danaher Corporation (NYSE:DHR) increased the target price from $0.00 to $96.00. At the time, this indicated a possible upside of 0.12%.

Just yesterday Danaher Corporation (NYSE:DHR) traded -4.11% lower at $82.89. Danaher Corporation’s 50-day moving average is $86.21 and its 200-day moving average is $81.56. The last stock price is up 1.63% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.03% over the same time period. 8,816,984 shares of DHR traded hands, up from an average trading volume of 2,280,820

Recent Performance Chart

Danaher Corporation (NYSE:DHR)

Danaher Corporation has 52 week low of $72.34 and a 52 week high of $102.79 with a PE ratio of 22.70 and has a market capitalization of $0.

Also covering Danaher Corporation's target, a total of 20 analysts have released a research note on DHR. The one year target is $104.22 with nine analysts rating the company a strong buy, six analysts rating the company a buy, eight analysts rating the company a hold, zero analysts rating the company a underperform, and lastly zero analysts rating the company a sell.

General Company Details For Danaher Corporation (NYSE:DHR)

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.